0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Radiopharmaceuticals Market by Type (Diagnostic Radioisotopes, Therapeutic Radioisotopes), by Application (Oncology, Cardiology, Others), Region - Global Growth & Forecast to 2027
Published Date: April 2020
|
Report Code: QYRE-Othe-1Y270
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
radiopharmaceuticals market

Radiopharmaceuticals Market by Type (Diagnostic Radioisotopes, Therapeutic Radioisotopes), by Application (Oncology, Cardiology, Others), Region - Global Growth & Forecast to 2027

Code: QYRE-Othe-1Y270
Report
April 2020
117 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
RADIOPHARMACEUTICALS MARKET OVERVIEW

The global Radiopharmaceuticals market was valued at US$ 5762.3 million in 2019 and is expected to reach US$ 9934.1 million by the end of 2026, growing at a CAGR of 8.0% during 2021-2026.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

In the last several years, global market of Radiopharmaceuticals developed year by year, with an average growth rate of 8.02% for the sales. In 2016, global revenue of Radiopharmaceuticals is nearly 4546 M USD; the sale is about 130 M Dose.

This report focuses on Radiopharmaceuticals volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Radiopharmaceuticals market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc. 

MARKET SEGMENT ANALYSIS

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

 

SEGMENT BY TYPE, THE RADIOPHARMACEUTICALS MARKET IS SEGMENTED INTO

  • Diagnostic Radioisotopes
  • Therapeutic Radioisotopes

 

SEGMENT BY APPLICATION

  • Oncology
  • Cardiology
  • Other

 

GLOBAL RADIOPHARMACEUTICALS MARKET: REGIONAL ANALYSIS

The Radiopharmaceuticals market is analyzed and market size information is provided by regions (countries). The report includes a country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

 

THE KEY REGIONS COVERED IN THE RADIOPHARMACEUTICALS MARKET REPORT ARE:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • U.A.E

 

GLOBAL RADIOPHARMACEUTICALS MARKET: COMPETITIVE ANALYSIS

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

 

THE MAJOR PLAYERS IN THE GLOBAL RADIOPHARMACEUTICALS MARKET INCLUDE:

  • Bracco Imaging
  • Bayer
  • Mallinckrodt
  • Nordion
  • Triad Isotopes
  • Lantheus
  • IBA Group
  • GE Healthcare
  • China Isotope & Radiation
  • Jubilant Pharma
  • Eli Lilly
  • Advanced Accelerator Applications
  • SIEMENS
  • Dongcheng
  • Navidea
TABLE OF CONTENT:

 

1 Radiopharmaceuticals Market Overview

    1.1 Product Overview and Scope of Radiopharmaceuticals

    1.2 Radiopharmaceuticals Segment by Type

        1.2.1 Global Radiopharmaceuticals Sales Growth Rate Comparison by Type (2021-2026)

        1.2.2 Diagnostic Radioisotopes

        1.2.3 Therapeutic Radioisotopes

    1.3 Radiopharmaceuticals Segment by Application

        1.3.1 Radiopharmaceuticals Sales Comparison by Application: 2020 VS 2026

        1.3.2 Oncology

        1.3.3 Cardiology

        1.3.4 Other

    1.4 Global Radiopharmaceuticals Market Size Estimates and Forecasts

        1.4.1 Global Radiopharmaceuticals Revenue 2015-2026

        1.4.2 Global Radiopharmaceuticals Sales 2015-2026

        1.4.3 Radiopharmaceuticals Market Size by Region: 2020 Versus 2026

 

2 Global Radiopharmaceuticals Market Competition by Manufacturers

    2.1 Global Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020)

    2.2 Global Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)

    2.3 Global Radiopharmaceuticals Average Price by Manufacturers (2015-2020)

    2.4 Manufacturers Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type

    2.5 Radiopharmaceuticals Market Competitive Situation and Trends

        2.5.1 Radiopharmaceuticals Market Concentration Rate

        2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue

        2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

    2.7 Primary Interviews with Key Radiopharmaceuticals Players (Opinion Leaders)

 

3 Radiopharmaceuticals Retrospective Market Scenario by Region

    3.1 Global Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020

    3.2 Global Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020

    3.3 North America Radiopharmaceuticals Market Facts & Figures by Country

        3.3.1 North America Radiopharmaceuticals Sales by Country

        3.3.2 North America Radiopharmaceuticals Sales by Country

        3.3.3 U.S.

        3.3.4 Canada

    3.4 Europe Radiopharmaceuticals Market Facts & Figures by Country

        3.4.1 Europe Radiopharmaceuticals Sales by Country

        3.4.2 Europe Radiopharmaceuticals Sales by Country

        3.4.3 Germany

        3.4.4 France

        3.4.5 U.K.

        3.4.6 Italy

        3.4.7 Russia

    3.5 Asia Pacific Radiopharmaceuticals Market Facts & Figures by Region

        3.5.1 Asia Pacific Radiopharmaceuticals Sales by Region

        3.5.2 Asia Pacific Radiopharmaceuticals Sales by Region

        3.5.3 China

        3.5.4 Japan

        3.5.5 South Korea

        3.5.6 India

        3.5.7 Australia

        3.5.8 Taiwan

        3.5.9 Indonesia

        3.5.10 Thailand

        3.5.11 Malaysia

        3.5.12 Philippines

        3.5.13 Vietnam

    3.6 Latin America Radiopharmaceuticals Market Facts & Figures by Country

        3.6.1 Latin America Radiopharmaceuticals Sales by Country

        3.6.2 Latin America Radiopharmaceuticals Sales by Country

        3.6.3 Mexico

        3.6.3 Brazil

        3.6.3 Argentina

    3.7 Middle East and Africa Radiopharmaceuticals Market Facts & Figures by Country

        3.7.1 Middle East and Africa Radiopharmaceuticals Sales by Country

        3.7.2 Middle East and Africa Radiopharmaceuticals Sales by Country

        3.7.3 Turkey

        3.7.4 Saudi Arabia

        3.7.5 U.A.E

 

4 Global Radiopharmaceuticals Historic Market Analysis by Type

    4.1 Global Radiopharmaceuticals Sales Market Share by Type (2015-2020)

    4.2 Global Radiopharmaceuticals Revenue Market Share by Type (2015-2020)

    4.3 Global Radiopharmaceuticals Price Market Share by Type (2015-2020)

    4.4 Global Radiopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

 

5 Global Radiopharmaceuticals Historic Market Analysis by Application

    5.1 Global Radiopharmaceuticals Sales Market Share by Application (2015-2020)

    5.2 Global Radiopharmaceuticals Revenue Market Share by Application (2015-2020)

    5.3 Global Radiopharmaceuticals Price by Application (2015-2020)

 

6 Company Profiles and Key Figures in Radiopharmaceuticals Business

    6.1 Bracco Imaging

        6.1.1 Corporation Information

        6.1.2 Bracco Imaging Description, Business Overview and Total Revenue

        6.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)

        6.1.4 Bracco Imaging Products Offered

        6.1.5 Bracco Imaging Recent Development

    6.2 Bayer

        6.2.1 Bayer Radiopharmaceuticals Production Sites and Area Served

        6.2.2 Bayer Description, Business Overview and Total Revenue

        6.2.3 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)

        6.2.4 Bayer Products Offered

        6.2.5 Bayer Recent Development

    6.3 Mallinckrodt

        6.3.1 Mallinckrodt Radiopharmaceuticals Production Sites and Area Served

        6.3.2 Mallinckrodt Description, Business Overview and Total Revenue

        6.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)

        6.3.4 Mallinckrodt Products Offered

        6.3.5 Mallinckrodt Recent Development

    6.4 Nordion

        6.4.1 Nordion Radiopharmaceuticals Production Sites and Area Served

        6.4.2 Nordion Description, Business Overview and Total Revenue

        6.4.3 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)

        6.4.4 Nordion Products Offered

        6.4.5 Nordion Recent Development

    6.5 Triad Isotopes

        6.5.1 Triad Isotopes Radiopharmaceuticals Production Sites and Area Served

        6.5.2 Triad Isotopes Description, Business Overview and Total Revenue

        6.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)

        6.5.4 Triad Isotopes Products Offered

        6.5.5 Triad Isotopes Recent Development

    6.6 Lantheus

        6.6.1 Lantheus Radiopharmaceuticals Production Sites and Area Served

        6.6.2 Lantheus Description, Business Overview and Total Revenue

        6.6.3 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)

        6.6.4 Lantheus Products Offered

        6.6.5 Lantheus Recent Development

    6.7 IBA Group

        6.6.1 IBA Group Radiopharmaceuticals Production Sites and Area Served

        6.6.2 IBA Group Description, Business Overview and Total Revenue

        6.6.3 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)

        6.4.4 IBA Group Products Offered

        6.7.5 IBA Group Recent Development

    6.8 GE Healthcare

        6.8.1 GE Healthcare Radiopharmaceuticals Production Sites and Area Served

        6.8.2 GE Healthcare Description, Business Overview and Total Revenue

        6.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)

        6.8.4 GE Healthcare Products Offered

        6.8.5 GE Healthcare Recent Development

    6.9 China Isotope & Radiation

        6.9.1 China Isotope & Radiation Radiopharmaceuticals Production Sites and Area Served

        6.9.2 China Isotope & Radiation Description, Business Overview and Total Revenue

        6.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)

        6.9.4 China Isotope & Radiation Products Offered

        6.9.5 China Isotope & Radiation Recent Development

    6.10 Jubilant Pharma

        6.10.1 Jubilant Pharma Radiopharmaceuticals Production Sites and Area Served

        6.10.2 Jubilant Pharma Description, Business Overview and Total Revenue

        6.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)

        6.10.4 Jubilant Pharma Products Offered

        6.10.5 Jubilant Pharma Recent Development

    6.11 Eli Lilly

        6.11.1 Eli Lilly Radiopharmaceuticals Production Sites and Area Served

        6.11.2 Eli Lilly Radiopharmaceuticals Description, Business Overview and Total Revenue

        6.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)

        6.11.4 Eli Lilly Products Offered

        6.11.5 Eli Lilly Recent Development

    6.12 Advanced Accelerator Applications

        6.12.1 Advanced Accelerator Applications Radiopharmaceuticals Production Sites and Area Served

        6.12.2 Advanced Accelerator Applications Radiopharmaceuticals Description, Business Overview and Total Revenue

        6.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)

        6.12.4 Advanced Accelerator Applications Products Offered

        6.12.5 Advanced Accelerator Applications Recent Development

    6.13 SIEMENS

        6.13.1 SIEMENS Radiopharmaceuticals Production Sites and Area Served

        6.13.2 SIEMENS Radiopharmaceuticals Description, Business Overview and Total Revenue

        6.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)

        6.13.4 SIEMENS Products Offered

        6.13.5 SIEMENS Recent Development

    6.14 Dongcheng

        6.14.1 Dongcheng Radiopharmaceuticals Production Sites and Area Served

        6.14.2 Dongcheng Radiopharmaceuticals Description, Business Overview and Total Revenue

        6.14.3 Dongcheng Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)

        6.14.4 Dongcheng Products Offered

        6.14.5 Dongcheng Recent Development

    6.15 Navidea

        6.15.1 Navidea Radiopharmaceuticals Production Sites and Area Served

        6.15.2 Navidea Radiopharmaceuticals Description, Business Overview and Total Revenue

        6.15.3 Navidea Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)

        6.15.4 Navidea Products Offered

        6.15.5 Navidea Recent Development

 

7 Radiopharmaceuticals Manufacturing Cost Analysis

    7.1 Radiopharmaceuticals Key Raw Materials Analysis

       7.1.1 Key Raw Materials

       7.1.2 Key Raw Materials Price Trend

       7.1.3 Key Suppliers of Raw Materials

    7.2 Proportion of Manufacturing Cost Structure

    7.3 Manufacturing Process Analysis of Radiopharmaceuticals

    7.4 Radiopharmaceuticals Industrial Chain Analysis

 

8 Marketing Channel, Distributors and Customers

    8.1 Marketing Channel

    8.2 Radiopharmaceuticals Distributors List

    8.3 Radiopharmaceuticals Customers

 

9 Market Dynamics

9.1 Market Trends

9.2 Opportunities and Drivers

9.3 Challenges

9.4 Porter's Five Forces Analysis

 

10 Global Market Forecast

    10.1 Global Radiopharmaceuticals Market Estimates and Projections by Type

        10.1.1 Global Forecasted Sales of Radiopharmaceuticals by Type (2021-2026)

        10.1.2 Global Forecasted Revenue of Radiopharmaceuticals by Type (2021-2026)

    10.2 Radiopharmaceuticals Market Estimates and Projections by Application

        10.2.1 Global Forecasted Sales of Radiopharmaceuticals by Application (2021-2026)

        10.2.2 Global Forecasted Revenue of Radiopharmaceuticals by Application (2021-2026)

    10.3 Radiopharmaceuticals Market Estimates and Projections by Region

        10.3.1 Global Forecasted Sales of Radiopharmaceuticals by Region (2021-2026)

        10.3.2 Global Forecasted Revenue of Radiopharmaceuticals by Region (2021-2026)

    10.4 North America Radiopharmaceuticals Estimates and Projections (2021-2026)

    10.5 Europe Radiopharmaceuticals Estimates and Projections (2021-2026)

    10.6 Asia Pacific Radiopharmaceuticals Estimates and Projections (2021-2026)

    10.7 Latin America Radiopharmaceuticals Estimates and Projections (2021-2026)

    10.8 Middle East and Africa Radiopharmaceuticals Estimates and Projections (2021-2026)

 

11 Research Finding and Conclusion

 

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

LIST OF TABLES & FIGURES :

 

Table 1. Global Radiopharmaceuticals Sales (K Dose) Growth Rate Comparison by Type (2015-2026)

Table 2. Global Radiopharmaceuticals Sales (K Dose) Comparison by Application: 2020 VS 2026

Table 3. Global Radiopharmaceuticals Market Size by Type (K Dose) (US$ Million) (2020 VS 2026)

Table 4. Global Key Radiopharmaceuticals Manufacturers Covered in This Study

Table 5. Global Radiopharmaceuticals Sales (K Dose) by Manufacturers (2015-2020)

Table 6. Global Radiopharmaceuticals Sales Share by Manufacturers (2015-2020)

Table 7. Global Radiopharmaceuticals Revenue (Million USD) by Manufacturers (2015-2020)

Table 8. Global Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)

Table 9. Global Market Radiopharmaceuticals Average Price (USD/Dose) of Key Manufacturers (2015-2020)

Table 10. Manufacturers Radiopharmaceuticals Sales Sites and Area Served

Table 11. Manufacturers Radiopharmaceuticals Product Types

Table 12. Global Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 13. Global Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceuticals as of 2019)

Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans

Table 15. Main Points Interviewed from Key Radiopharmaceuticals Players

Table 16. Global Radiopharmaceuticals Sales (K Dose) by Region (2015-2020)

Table 17. Global Radiopharmaceuticals Sales Market Share by Region (2015-2020)

Table 18. Global Radiopharmaceuticals Revenue (Million US$) by Region (2015-2020)

Table 19. Global Radiopharmaceuticals Revenue Market Share by Region (2015-2020)

Table 20. North America Radiopharmaceuticals Sales by Country (2015-2020) (K Dose)

Table 21. North America Radiopharmaceuticals Sales Market Share by Country (2015-2020)

Table 22. North America Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)

Table 23. North America Radiopharmaceuticals Revenue Market Share by Country (2015-2020)

Table 24. Europe Radiopharmaceuticals Sales by Country (2015-2020) (K Dose)

Table 25. Europe Radiopharmaceuticals Sales Market Share by Country (2015-2020)

Table 26. Europe Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)

Table 27. Europe Radiopharmaceuticals Revenue Market Share by Country (2015-2020)

Table 28. Asia Pacific Radiopharmaceuticals Sales by Region (2015-2020) (K Dose)

Table 29. Asia Pacific Radiopharmaceuticals Sales Market Share by Region (2015-2020)

Table 30. Asia Pacific Radiopharmaceuticals Revenue by Region (2015-2020) (US$ Million)

Table 31. Asia Pacific Radiopharmaceuticals Revenue Market Share by Region (2015-2020)

Table 32. Latin America Radiopharmaceuticals Sales by Country (2015-2020) (K Dose)

Table 33. Latin America Radiopharmaceuticals Sales Market Share by Country (2015-2020)

Table 34. Latin America Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)

Table 35. Latin America Radiopharmaceuticals Revenue Market Share by Country (2015-2020)

Table 36. Middle East and Africa Radiopharmaceuticals Sales by Country (2015-2020) (K Dose)

Table 37. Middle East and Africa Radiopharmaceuticals Sales Market Share by Country (2015-2020)

Table 38. Middle East and Africa Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)

Table 39. Middle East and Africa Radiopharmaceuticals Revenue Market Share by Country (2015-2020)

Table 40. Global Radiopharmaceuticals Sales (K Dose) by Type (2015-2020)

Table 41. Global Radiopharmaceuticals Sales Share by Type (2015-2020)

Table 42. Global Radiopharmaceuticals Revenue (Million US$) by Type (2015-2020)

Table 43. Global Radiopharmaceuticals Revenue Share by Type (2015-2020)

Table 44. Global Radiopharmaceuticals Price (USD/Dose) by Type (2015-2020)

Table 45. Global Radiopharmaceuticals Sales (K Dose) by Application (2015-2020)

Table 46. Global Radiopharmaceuticals Sales Market Share by Application (2015-2020)

Table 47. Global Radiopharmaceuticals Sales Growth Rate by Application (2015-2020)

Table 48. Bracco Imaging Radiopharmaceuticals Corporation Information

Table 49. Bracco Imaging Description and Business Overview

Table 50. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 51. Bracco Imaging Main Product

Table 52. Bracco Imaging Recent Development

Table 53. Bayer Radiopharmaceuticals Corporation Information

Table 54. Bayer Corporation Information

Table 55. Bayer Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 56. Bayer Main Product

Table 57. Bayer Recent Development

Table 58. Mallinckrodt Radiopharmaceuticals Corporation Information

Table 59. Mallinckrodt Corporation Information

Table 60. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 61. Mallinckrodt Main Product

Table 62. Mallinckrodt Recent Development

Table 63. Nordion Radiopharmaceuticals Corporation Information

Table 64. Nordion Corporation Information

Table 65. Nordion Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 66. Nordion Main Product

Table 67. Nordion Recent Development

Table 68. Triad Isotopes Radiopharmaceuticals Corporation Information

Table 69. Triad Isotopes Corporation Information

Table 70. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 71. Triad Isotopes Main Product

Table 72. Triad Isotopes Recent Development

Table 73. Lantheus Radiopharmaceuticals Corporation Information

Table 74. Lantheus Corporation Information

Table 75. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 76. Lantheus Main Product

Table 77. Lantheus Recent Development

Table 78. IBA Group Radiopharmaceuticals Corporation Information

Table 79. IBA Group Corporation Information

Table 80. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 81. IBA Group Main Product

Table 82. IBA Group Recent Development

Table 83. GE Healthcare Radiopharmaceuticals Corporation Information

Table 84. GE Healthcare Corporation Information

Table 85. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 86. GE Healthcare Main Product

Table 87. GE Healthcare Recent Development

Table 88. China Isotope & Radiation Radiopharmaceuticals Corporation Information

Table 89. China Isotope & Radiation Corporation Information

Table 90. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 91. China Isotope & Radiation Main Product

Table 92. China Isotope & Radiation Recent Development

Table 93. Jubilant Pharma Radiopharmaceuticals Corporation Information

Table 94. Jubilant Pharma Corporation Information

Table 95. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 96. Jubilant Pharma Main Product

Table 97. Jubilant Pharma Recent Development

Table 98. Eli Lilly Radiopharmaceuticals Corporation Information

Table 99. Eli Lilly Corporation Information

Table 100. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 101. Eli Lilly Main Product

Table 102. Eli Lilly Recent Development

Table 103. Advanced Accelerator Applications Radiopharmaceuticals Corporation Information

Table 104. Advanced Accelerator Applications Corporation Information

Table 105. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 106. Advanced Accelerator Applications Main Product

Table 107. Advanced Accelerator Applications Recent Development

Table 108. SIEMENS Radiopharmaceuticals Corporation Information

Table 109. SIEMENS Corporation Information

Table 110. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 111. SIEMENS Main Product

Table 112. SIEMENS Recent Development

Table 113. Dongcheng Radiopharmaceuticals Corporation Information

Table 114. Dongcheng Corporation Information

Table 115. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 116. Dongcheng Main Product

Table 117. Dongcheng Recent Development

Table 118. Navidea Radiopharmaceuticals Corporation Information

Table 119. Navidea Corporation Information

Table 120. Navidea Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

Table 121. Navidea Main Product

Table 122. Navidea Recent Development

Table 123. Sales Base and Market Concentration Rate of Raw Material

Table 124. Key Suppliers of Raw Materials

Table 125. Radiopharmaceuticals Distributors List

Table 126. Radiopharmaceuticals Customers List

Table 127. Market Key Trends

Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 129. Key Challenges

Table 130. Global Radiopharmaceuticals Sales (K Dose) Forecast by Type (2021-2026)

Table 131. Global Radiopharmaceuticals Sales Market Share Forecast by Type (2021-2026)

Table 132. Global Radiopharmaceuticals Revenue (Million US$) Forecast by Type (2021-2026)

Table 133. Global Radiopharmaceuticals Revenue (Million US$) Market Share Forecast by Type (2021-2026)

Table 134. Global Radiopharmaceuticals Sales (K Dose) Forecast by Application (2021-2026)

Table 135. Global Radiopharmaceuticals Revenue (Million US$) Forecast by Application (2021-2026)

Table 136. Global Radiopharmaceuticals Sales (K Dose) Forecast by Region (2021-2026)

Table 137. Global Radiopharmaceuticals Sales Market Share Forecast by Region (2021-2026)

Table 138. Global Radiopharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)

Table 139. Global Radiopharmaceuticals Revenue Market Share Forecast by Region (2021-2026)

Table 140. Research Programs/Design for This Report

Table 141. Key Data Information from Secondary Sources

Table 142. Key Data Information from Primary Sources

List of Figures

Figure 1. Picture of Radiopharmaceuticals

Figure 2. Global Radiopharmaceuticals Sales Market Share by Type: 2020 VS 2026

Figure 3. Diagnostic Radioisotopes Product Picture

Figure 4. Therapeutic Radioisotopes Product Picture

Figure 5. Global Radiopharmaceuticals Consumption Market Share by Application: 2020 VS 2026

Figure 6. Oncology

Figure 7. Cardiology

Figure 8. Other

Figure 9. Global Radiopharmaceuticals Market Size 2015-2026 (US$ Million)

Figure 10. Global Radiopharmaceuticals Sales Capacity (K Dose) (2015-2026)

Figure 11. Global Radiopharmaceuticals Market Size Market Share by Region: 2020 Versus 2026

Figure 12. Radiopharmaceuticals Sales Share by Manufacturers in 2020

Figure 13. Global Radiopharmaceuticals Revenue Share by Manufacturers in 2019

Figure 14. The Global 5 and 10 Largest Players: Market Share by Radiopharmaceuticals Revenue in 2019

Figure 15. Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 16. Global Radiopharmaceuticals Sales Market Share by Region (2015-2020)

Figure 17. Global Radiopharmaceuticals Sales Market Share by Region in 2019

Figure 18. Global Radiopharmaceuticals Revenue Market Share by Region (2015-2020)

Figure 19. Global Radiopharmaceuticals Revenue Market Share by Region in 2019

Figure 20. North America Radiopharmaceuticals Sales Market Share by Country in 2019

Figure 21. North America Radiopharmaceuticals Revenue Market Share by Country in 2019

Figure 22. U.S. Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 23. U.S. Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 24. Canada Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 25. Canada Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 26. Europe Radiopharmaceuticals Sales Market Share by Country in 2019

Figure 27. Europe Radiopharmaceuticals Revenue Market Share by Country in 2019

Figure 28. Germany Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 29. Germany Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 30. France Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 31. France Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 32. U.K. Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 33. U.K. Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 34. Italy Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 35. Italy Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 36. Russia Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 37. Russia Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 38. Asia Pacific Radiopharmaceuticals Sales Market Share by Region in 2019

Figure 39. Asia Pacific Radiopharmaceuticals Revenue Market Share by Region in 2019

Figure 40. China Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 41. China Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 42. Japan Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 43. Japan Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 44. South Korea Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 45. South Korea Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 46. India Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 47. India Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 48. Australia Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 49. Australia Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 50. Taiwan Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 51. Taiwan Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 52. Indonesia Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 53. Indonesia Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 54. Thailand Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 55. Thailand Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 56. Malaysia Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 57. Malaysia Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 58. Philippines Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 59. Philippines Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 60. Vietnam Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 61. Vietnam Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 62. Latin America Radiopharmaceuticals Sales Market Share by Country in 2019

Figure 63. Latin America Radiopharmaceuticals Revenue Market Share by Country in 2019

Figure 64. Mexico Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 65. Mexico Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 66. Brazil Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 67. Brazil Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 68. Argentina Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 69. Argentina Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. Middle East and Africa Radiopharmaceuticals Sales Market Share by Country in 2019

Figure 71. Middle East and Africa Radiopharmaceuticals Revenue Market Share by Country in 2019

Figure 72. Turkey Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 73. Turkey Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 74. Saudi Arabia Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 75. Saudi Arabia Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 76. U.A.E Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)

Figure 77. U.A.E Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. Sales Market Share of Radiopharmaceuticals by Type (2015-2020)

Figure 79. Sales Market Share of Radiopharmaceuticals by Type in 2019

Figure 80. Revenue Share of Radiopharmaceuticals by Type (2015-2020)

Figure 81. Revenue Market Share of Radiopharmaceuticals by Type in 2019

Figure 82. Global Radiopharmaceuticals Sales Growth by Type (2015-2020) (K Dose)

Figure 83. Global Radiopharmaceuticals Sales Market Share by Application (2015-2020)

Figure 84. Global Radiopharmaceuticals Sales Market Share by Application in 2019

Figure 85. Global Revenue Share of Radiopharmaceuticals by Application (2015-2020)

Figure 86. Global Revenue Share of Radiopharmaceuticals by Application in 2020

Figure 87. Bracco Imaging Total Revenue (US$ Million): 2019 Compared with 2018

Figure 88. Bayer Total Revenue (US$ Million): 2019 Compared with 2018

Figure 89. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018

Figure 90. Nordion Total Revenue (US$ Million): 2019 Compared with 2018

Figure 91. Triad Isotopes Total Revenue (US$ Million): 2019 Compared with 2018

Figure 92. Lantheus Total Revenue (US$ Million): 2019 Compared with 2018

Figure 93. IBA Group Total Revenue (US$ Million): 2019 Compared with 2018

Figure 94. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018

Figure 95. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018

Figure 96. Jubilant Pharma Total Revenue (US$ Million): 2019 Compared with 2018

Figure 97. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018

Figure 98. Advanced Accelerator Applications Total Revenue (US$ Million): 2019 Compared with 2018

Figure 99. SIEMENS Total Revenue (US$ Million): 2019 Compared with 2018

Figure 100. Dongcheng Total Revenue (US$ Million): 2019 Compared with 2018

Figure 101. Navidea Total Revenue (US$ Million): 2019 Compared with 2018

Figure 102. Price Trend of Key Raw Materials

Figure 103. Manufacturing Cost Structure of Radiopharmaceuticals

Figure 104. Manufacturing Process Analysis of Radiopharmaceuticals

Figure 105. Radiopharmaceuticals Industrial Chain Analysis

Figure 106. Channels of Distribution

Figure 107. Distributors Profiles

Figure 108. Porter's Five Forces Analysis

Figure 109. North America Radiopharmaceuticals Sales (K Dose) and Growth Rate Forecast (2021-2026)

Figure 110. North America Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 111. Europe Radiopharmaceuticals Sales (K Dose) and Growth Rate Forecast (2021-2026)

Figure 112. Europe Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 113. Latin America Radiopharmaceuticals Sales (K Dose) and Growth Rate Forecast (2021-2026)

Figure 114. Latin America Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 115. Middle East and Africa Radiopharmaceuticals Sales (K Dose) and Growth Rate Forecast (2021-2026)

Figure 116. Middle East and Africa Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 117. Asia Pacific Radiopharmaceuticals Sales (K Dose) and Growth Rate Forecast (2021-2026)

Figure 118. Asia Pacific Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 119. Bottom-up and Top-down Approaches for This Report

Figure 120. Data Triangulation

Figure 121. Key Executives Interviewed

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$2900
This license allows only one user to access the PDF.

Electronic (PDF)
$5800
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

Global and Japan qPCR Kits Market Insights Forecast to 2027
Global and Japan qPCR Kits Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-39Y7542
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Human ELISA Kits Market Insights Forecast to 2027
Global and China Human ELISA Kits Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-24Z7484
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and United States PCR Amplifier Market Insights Forecast to 2027
Global and United States PCR Amplifier Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-6W7895
Wed Nov 24 00:00:00 UTC 2021

Add to Cart

Global and China Porcine ELISA Kits Market Insights Forecast to 2027
Global and China Porcine ELISA Kits Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-37N7620
Wed Nov 24 00:00:00 UTC 2021

Add to Cart